ImmunoACT
PrivateLast Round
Series B
May 31, 2023
Est. Valuation
$133.61M
Total Funding Raised
$19.99M
Company Overview
ImmunoACT is a biotechnology company that develops and commercializes affordable CAR-T cell therapies for the treatment of various blood cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmunoACT Comparables
Compare ImmunoACT with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Immuneel Therapeutics | 92% | |
| Cellogen Therapeutics | 82% | |
| JW Therapeutics | 77% | |
ImmunoACT Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 31, 2023 | ||||
| Series A | Nov 19, 2021 | ||||
| Grant | Mar 8, 2019 |
Key People
Founding team and executive leadership
ImmunoACT Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Biotechnology Industry Research Assistance Council | Grant |
| Tata Trusts | Grant |
| Society for Innovation and Entrepreneurship | Accelerator, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2025
Presented NexCAR19 CAR-T therapy at ESTIC 2025.
- Feb 1, 2025
Launched NexCAR19, India's first indigenous CAR-T therapy.
ImmunoACT Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ImmunoACT's valuation, stock price, and market status.